KCT0002664招募中未知
Efficacy and safety of ASE(Aster spathulifolius Maxim. extract) on reducing body weight and body fat in overweight subjects; A 12week, Randomized, Double-blind, Placebo-Controlled Clinical Trial
ewtree0 个研究点目标入组 80 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 20(Year) 至 70(Year)（—）
- 性别
- All
入选标准
- •(1) Adult men and women aged 20 or older and younger than 70 years
- •(2) Those with a body mass index (BMI) of 23 kg / m2 or more and less than 30 kg / m2
- •(3) A person who agrees to participate in the Applicable Human Body Examination and who has voluntarily signed a written consent form (or legal representative)
排除标准
- •(1) Subjects with severe cerebrovascular disease (cerebral infarction, cerebral hemorrhage, etc.), heart disease (angina pectoris, myocardial infarction, heart failure, arrhythmia requiring treatment) within the last 6 months If the subject has a history but is clinically stable, he or she can participate in the test by the examiner's judgment.)
- •(2) Uncontrolled hypertension patients (blood pressure of 160/100 mmHg or more, after 10 minutes of test subjects)
- •(3) Diabetic patients taking fasting blood glucose levels greater than 126 mg / dl, randomized blood glucose levels greater than 200 mg / dl, or taking oral hypoglycemic agents or insulin
- •(4) TSH not more than 0.1 uU / ml or not less than 10 uU / ml
- •(5) Creatinine is at least twice the normal upper limit of the testing laboratory
- •(6) AST (GOT) or ALT (GPT) is at least three times the normal upper limit of the test laboratory.
- •(7) People who complain of severe gastrointestinal symptoms such as heartburn and indigestion
- •(8) Drugs that affect body weight within the past month (including absorption inhibitors and appetite suppressants, health functional foods / supplements related to obesity improvement, psychiatric drugs such as depression, beta blockers, diuretics, birth control pills, steroids, Who are taking medicines to treat hyperlipidemia
- •(9) Those who participated in the commercial obesity program within the last 3 months
- •(10) Have participated or planned to participate in other clinical trials within the past month
- •(11) Those who are admitted to hospital, medication or rehabilitation due to heart disease, central nervous disorder, etc. through medical history
- •(12) A person who is judged to have trouble with the test due to excessive alcohol consumption
- •(13) Those who are judged to be unable to exercise due to musculoskeletal disorders
- •(14) A person who is pregnant or who has a pregnancy plan during the period of the test
- •(15) Any person who is found to be unsuitable for any other reason
研究者
相似试验
招募中
4 期
Evaluation of efficacy and safety of ASPURUS for management of menopausal symptomsCTRI/2023/08/056569Waleria Healthtech Pvt. Ltd.,
已完成
不适用
Comparing Efficacy of Chest Tube drainage and Needle Aspiration for Pneumothorax Treatment in neonatesPneumothorax, Chest Tube, Needle Aspiration,.PneumothoraxIRCT20190810044491N1Iran University of Medical Sciences116
已完成
不适用
Evaluation of efficacy and safety of anti-sclerostin antibody romosozumab for osteoporosis in patients undergoing hemodialysisosteoporosis, end stage renal diseaseJPRN-UMIN000037579Tokai University School of Medicine25
尚未招募
2 期
Evaluation of efficacy and safety of Polyherbal unani paste for local Application in the Management of Knee OsteoarthritisCTRI/2024/03/063596Hakim Syed Ziaul Hasan Government Unani Medical College and Hospital
尚未招募
4 期
Comparison of drugs used in the treatment of blood cancer in children.Escherichia coli asparaginase vs pegylated asparaginaseCTRI/2019/06/019520Dr Anand Srinivasan